10th Annual Biosimilars and Biologics Conference

10th Annual Biosimilars and Biologics Conference is organized by SMi Group Ltd and will be held from Sep 25 - 26, 2019 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

Who Should Attend?
Presidents, Vice Presidents, Managing Directors, Directors, Associate Directors, Chiefs, Heads, Principals, Managers, and Analysts of:
•  Biosimilar Development
• Product Development 
• Commercialization
• Market Access 
• Medical Affairs
• Intellectual Property
•  Biologics
•  Biopharmaceuticals
• Research and Development
• Generics 
• Biobetters
• Business Development 
• Strategic Marketing
• Drug Development
•  Clinical Trials
• Immunogenicity Studies

Description:
The biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.

With the expiry dates of major patents fast approaching, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians, and investors?

Benefits of Attending:
• HEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers
• DISCUSS the possible changes in regulatory approval of biosimilars in the UK post-Brexit, and how this will impact market entry
• EXPLORE the latest methods in use to maintain the relationship between stakeholders, doctors, and patients, with the influence of governing bodies
•  REVIEW FDA regulations for the approval of Biosimilars and the latest approvals

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS - Tuesday 24th September 2019

Prices:
Conference and 2 Workshops: GBP 2697.0,
Conference and 1 Workshop: GBP 2098.0,
Conference Only: GBP 1499.0,
2 Workshops: GBP 1198.0,
1 Workshop Only: GBP 599.0,
Conference Speaker Presentations: GBP 499.0

Speakers:
Chaired by Michel Mikhail, International Expert Regulatory Affairs, Global Expert Biosimilars, Anne Cook, Biologicals Quality Assessor, Medicines and Healthcare Products Regulatory Agency, Anne Cook, Biologicals Quality Assessor, Medicines and Healthcare Products Regulatory Agency, Louis Boon, CSO, Bioceros, Steiner Madsen, Medical Director, Norwegian Medicines Agency, Sue Naeyaert, Global Head Government Affairs, Fresenius Kabi, Aurelio Arias, Senior Thought Leadership Consultant, IQVIA

Time: 8:30 am - 4:30 pm

Additional details will be posted as soon as they are available.